Clinical Trial Search

Primary: Change in Head Holding Active Time From Baseline to 6 Months — 83.63 Seconds

Primary: Blast Explosive Waves Experienced During the Training — 4.11; 4.29; 4.20; 4.0 number of blasts

Primary: Part 1: Number of Successful Deployments — 4; 0 number of successful deployments

Primary: Number of Participants Undergoing Acoustic Reflectance — 410; 410 participants — p=<0.05

Primary: Prevalence of Significant fNIRS Detection and Discrimination Responses — 4; 6; 1; 9 Participants

Primary: Change in Cranial Measurements as Measured by CVA — 11.6; 7.1 mm

Primary: Midline Localization — 0.9 mm

Primary: Number of Participants Free of Live Head Lice and Free of Viable Eggs — 57; 55; 32; 46 Participants

Primary: Subjective Report of Headpiece Comfort and Retention — 65; 70 Participants

Primary: Assessment of the Efficacy of the SEMD Device in Improving Vestibular Function Was Evaluated With Change in Pre Test to Post Test 1 Sensory Organization Test (SOT)…

Primary: High Risk Fall Rate — 0 falls/1000 patient days

Primary: Determine Average Number of Hits Between Groups — 896.43; 795.40; 144.67; 145.85 number of hits

Primary: Improvement in Speech Perception in Noise With EAS When Compared to the Preoperative Hearing Aid Alone Condition. — 42.2 percentage of words correct (CUNY)

Primary: Number of Participants With Critical Use Errors and Close Calls Associated With the Simulated Inhalation of One Dose Using TOBI Podhaler — 4 Participants

Primary: Cumulative Number of Use Errors Associated With the Usage of the Device According to Labelling — 4; 2 Errors

Primary: Percentage of Participants Who Completed the Study at 4 Weeks Without Adverse Events — 100 Percentage of participants

Primary: Difference in Dynamic Gait Index (DGI) — 0.77 units on a scale — p=0.018

Primary: Head Motion - Extension or Flexion — 16.5; 17.7 degrees of extension

Primary: Number of Participants Who Asked for Additional Information — 6 Participants

Primary: Apnoea-Hypopnoea Index (AHI) — 1.69; 1.73 Events/Hour

Primary: Visual Vertigo Analog Scale (VVAS) — 43.05; 36.84; 31.28; 21.41 score on a scale — p=0.027

Primary: Patient Satisfaction Survey — 65 percentage of satisfied subjects

Primary: Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months — 23; 3; 25; 45 Participants — p=0.01

Primary: Berg Balance Scale — 45; 44; 48; 47 Units on a continuous scale

Primary: Need for Endotracheal Intubation — 24; 8 Participants

Primary: Subjective Questionnaire of Comfort — 0; 0 score on a scale

Primary: Safety Outcome Measure: Proportion of Adverse Events (AEs) Related to Sophono Implant — 0.038 Proportion of Adverse Events

Primary: A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data — 77; 87 percentage of participants

Primary: Percentage of Participants Wearing Helmet — 65.6; 49.3; 80.5; 62.2 Percentage of Participants — p=<0.01

Primary: Harm to Skin From Attachment of Sensor to Forehead: Cuts, Bruising, Rash or Allergic Reactions to Adhesive. — 0; 14 Participants